{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:44:37Z","timestamp":1773294277076,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T00:00:00Z","timestamp":1101772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00228-004-0835-z","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T13:04:45Z","timestamp":1101733485000},"page":"759-764","source":"Crossref","is-referenced-by-count":33,"title":["Continuing clozapine treatment despite neutropenia"],"prefix":"10.1007","volume":"60","author":[{"given":"David","family":"Esposito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\ufffdd\ufffdric","family":"Rouillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\ufffdd\ufffdric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,30]]},"reference":[{"issue":"7935","key":"CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(75)90206-8","volume":"2","author":"J Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1975","unstructured":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4 J, Alhava E, Olkinuora M, Palva I (1975) Clozapine and agranulocytosis. Lancet 2(7935):611","journal-title":"Lancet"},{"issue":"2","key":"CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00393581","volume":"37","author":"A Chapelle De la","year":"1977","unstructured":"De la Chapelle A, Kari C, Nurminen M, Hernberg S (1977) Clozapine-induced agranulocytosis. A genetic and epidemiologic study. Hum Genet 37(2):183?194","journal-title":"Hum Genet"},{"issue":"11","key":"CR3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","volume":"324","author":"RJ Baldessarini","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR (1991) Clozapine. A novel antipsychotic agent. N Engl J Med 324(11):746?754","journal-title":"N Engl J Med"},{"issue":"8949","key":"CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(95)90469-7","volume":"345","author":"D Pickar","year":"1995","unstructured":"Pickar D (1995) Prospects for pharmacotherapy of schizophrenia. Lancet 345(8949):557?562","journal-title":"Lancet"},{"issue":"suppl 3","key":"CR5","first-page":"38","volume":"59","author":"JA Lieberman","year":"1998","unstructured":"Lieberman JA (1998) Maximizing clozapine therapy: managing side-effects. J Clin Psychiatry 59(suppl 3):38?43","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"JMJ Alvir","year":"1993","unstructured":"Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 329(3):162?167","journal-title":"N Engl J Med"},{"issue":"3","key":"CR7","first-page":"287","volume":"28","author":"M Hummer","year":"1992","unstructured":"Hummer M, Kurz M, Barnas C, Fleishhacker W (1992) Transient neutropenia induced by clozapine. Psychopharmacol Bull 28(3):287?290","journal-title":"Psychopharmacol Bull"},{"issue":"suppl 1","key":"CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199200071-00003","volume":"7","author":"JA Lieberman","year":"1992","unstructured":"Lieberman JA, Alvir JMJ (1992) A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors. Drug Saf 7(suppl 1):1?2","journal-title":"Drug Saf"},{"issue":"8804","key":"CR9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/0140-6736(92)91625-I","volume":"339","author":"AZ Safferman","year":"1992","unstructured":"Safferman AZ, Lieberman JA, Alvir JMJ, Howard A (1992) Rechallenge in clozapine-induced agranulocytosis. Lancet 339(8804):1296?1297","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-3956(66)90008-2","volume":"4","author":"D Mayfield","year":"1966","unstructured":"Mayfield D, Brown RG (1966) The clinical laboratory and electroencephalographic effects of lithium. J Psychiatr Res 4:207?219","journal-title":"J Psychiatr Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1176\/ajp.127.11.1559","volume":"127","author":"DL Murphy","year":"1971","unstructured":"Murphy DL, Goodwin FK, Bunney WE (1971) Leukocytosis during lithium treatment. Am J Psychiatry 127:1559?1561","journal-title":"Am J Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004850-199805000-00008","volume":"13","author":"P Blier","year":"1998","unstructured":"Blier P, Slater S, Measham T, Koch M, Wiviott G (1998) Lithium and clozapine-induced neutropenia\/agranulocytosis. Int Clin Psychopharmacol 13:137?140","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1176\/ajp.152.4.648","volume":"152","author":"Adityanjee","year":"1995","unstructured":"Adityanjee (1995) Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate. Am J Psychiatry 152(4):648?649","journal-title":"Am J Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM197801262980402","volume":"298","author":"G Rothstein","year":"1978","unstructured":"Rothstein G, Clarkson DR, Larsen W, Grosser BI, Athens JW (1978) Effect of lithium on neutrophil mass and production. N Engl J Med 298:178?180","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7326\/0003-4819-88-6-809_2","volume":"88","author":"RS Stein","year":"1978","unstructured":"Stein RS (1978) Lithium-induced granulocytosis. Ann Int Med 88:809?810","journal-title":"Ann Int Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01028358","volume":"40","author":"AJ Barrett","year":"1980","unstructured":"Barrett AJ (1980) Haematological effects of lithium and its use in the treatment of neutropenia. Blut 40:1?6","journal-title":"Blut"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-3223(94)91155-X","volume":"35","author":"MA Ozdemir","year":"1994","unstructured":"Ozdemir MA, Sofuoglu S, Tanrikulu G, Aldanmaz F, Esel E, Dundar S (1994) Lithium-induced hematologic changes in patients with bipolar affective disorder. Biol Psychiatry 35:210?213","journal-title":"Biol Psychiatry"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2796.1992.tb00527.x","volume":"231","author":"VS Gallicchio","year":"1992","unstructured":"Gallicchio VS, Hughes NK (1992) Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride. J Int Med 231:219?226","journal-title":"J Int Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0006-3223(93)90196-K","volume":"34","author":"B Sperner-Unterweger","year":"1993","unstructured":"Sperner-Unterweger B, Gaggl S, Fleischhacker WW, Barnas C, Herold M, Geissler D (1993) Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry 34:536?543","journal-title":"Biol Psychiatry"},{"issue":"4","key":"CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230109147387","volume":"13","author":"RA Boshes","year":"2001","unstructured":"Boshes RA, Manschreck TC, Desrosiers J, Candela S, Hanrahan-Boshes M (2001) Initiation of clozapine therapy in a patient with pre-existing leukopenia: a discussion of the rationale of current treatment options. Ann Clin Psychiatry 13(4):233?237","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/104454603322572697","volume":"13","author":"A Sporn","year":"2003","unstructured":"Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, Gochman P, Rapoport JL (2003) Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adolesc Psychopharmacol 13(3):401?404","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"CR22","first-page":"245","volume":"53","author":"C Barnas","year":"1992","unstructured":"Barnas C, Zwierzina H, Hummer J, Sperner-Unterweger B, Stern A, Fleischhacker WW (1992) Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. J Clin Psychiatry 53:245?247","journal-title":"J Clin Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1992.tb04574.x","volume":"80","author":"R Weide","year":"1992","unstructured":"Weide R, Koppler H, Heymanns J, Pfluger KH, Havemann K (1992) Successful treatment of clozapine-induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br J Haematol 80:557?559","journal-title":"Br J Haematol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1192\/bjp.162.5.686","volume":"162","author":"R Oren","year":"1993","unstructured":"Oren R, Granat E, Shtrussberg S, Matzner Y (1993) Clozapine-induced agranulocytosis treated with granulocyte macrophage stimulating factor. Br J Psychiatry 162:686?687","journal-title":"Br J Psychiatry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-199802000-00016","volume":"18","author":"PH Silverstone","year":"1998","unstructured":"Silverstone PH (1998) Prevention of clozapine-induced neutropenia by pre-treatment with lithium. J Clin Psychopharmacol 18:86?88","journal-title":"J Clin Psychopharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0140-6736(91)90410-Q","volume":"338","author":"SL Gerson","year":"1991","unstructured":"Gerson SL, Lieberman JA, Friedenberg WR, Lee D, Marx JJ, Meltzer H (1991) Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet 338:262?263","journal-title":"Lancet"},{"issue":"1","key":"CR27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-199300810-00011","volume":"8","author":"A Valevski","year":"1993","unstructured":"Valevski A, Modai I, Lahav M, Weitzman A (1993) Clozapine?lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol 8(1):63?65","journal-title":"Int Clin Psychopharmacol"},{"key":"CR28","first-page":"81","volume":"36","author":"B Jaremin","year":"1985","unstructured":"Jaremin B (1985) Immunoregulatory properties of some heavy metals in physiology and pathology conditions. Bull Inst Marit Trop Gdynia 36:81?88","journal-title":"Bull Inst Marit Trop Gdynia"},{"key":"CR29","unstructured":"Anonymous (2003) Clozaril prescribing information. In: Physicians? desk reference, 57th edn. Thomson Healthcare, Montvale"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/070674379604100504","volume":"41","author":"I Chin-Yee","year":"1996","unstructured":"Chin-Yee I, Bezchlibnyk-Butler K, Wong L (1996) Use of cytokines in clozapine-induced agranulocytosis. Can J Psychiatry 41:280?284","journal-title":"Can J Psychiatry"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1993.tb00789.x","volume":"234","author":"H Nielsen","year":"1993","unstructured":"Nielsen H (1993) Recombinant human granulocyte colony-stimulating factor (fhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis. J Intern Med 234:529?531","journal-title":"J Intern Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","volume":"325","author":"J Crawford","year":"1991","unstructured":"Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164?170","journal-title":"N Engl J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","volume":"324","author":"J Nemunaitis","year":"1991","unstructured":"Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M (1991) Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773?1778","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00002018-199200071-00007","volume":"7","author":"SL Gerson","year":"1992","unstructured":"Gerson SL, Meltzer HY (1992) Mechanisms of clozapine-induced agranulocytosis. Drug Saf 7(suppl 1):17?25","journal-title":"Drug Saf"},{"issue":"suppl 1","key":"CR35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00002018-199200071-00008","volume":"7","author":"PA Veys","year":"1992","unstructured":"Veys PA, Wilkes S, Shah S, Noyelle R, Hoffbrand AV (1992) Clinical experience of clozapine-induced neutropenia in the UK. Laboratory investigation using liquid culture systems and immunofluorocytometry. Drug Saf 7(suppl 1):26?32","journal-title":"Drug Saf"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1192\/bjp.172.1.82","volume":"172","author":"B Sperner-Unterweger","year":"1998","unstructured":"Sperner-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW (1998) Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Br J Psychiatry 172:82?84","journal-title":"Br J Psychiatry"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1192\/bjp.179.2.180","volume":"179","author":"P Conus","year":"2001","unstructured":"Conus P, Nanzer N, Baumann P (2001) An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia. Br J Psychiatry 179:180","journal-title":"Br J Psychiatry"},{"issue":"3","key":"CR38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.yic.0000062800.74434.6c","volume":"18","author":"S H\u00e4gg","year":"2003","unstructured":"H\u00e4gg S, Rosenius S, Spigset O (2003) Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Int Clin Psychopharmacol 18(3):173?174","journal-title":"Int Clin Psychopharmacol"},{"issue":"suppl B","key":"CR39","first-page":"139","volume":"55","author":"SL Gerson","year":"1994","unstructured":"Gerson SL (1994) G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 55(suppl B):139?142","journal-title":"J Clin Psychiatry"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2796.2001.00915.x","volume":"250","author":"J Palmblad","year":"2001","unstructured":"Palmblad J, Papadaki HA, Eliopoulos G (2001) Acute and chronic neutropenias. What is new? J Intern Med 250:476?480","journal-title":"J Intern Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0033-3182(86)72722-9","volume":"27","author":"R Balon","year":"1986","unstructured":"Balon R, Berchou R (1986) Hematologic side effects of psychotropic drugs. Psychosomatics 27:119?127","journal-title":"Psychosomatics"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0447.1977.tb00224.x","volume":"56","author":"HA Amsler","year":"1977","unstructured":"Amsler HA, Teerenhori L, Barth E, Hargula K, Vuopio P (1977) Agranulocytosis in patients treated with clozapine?a study of the Finnish epidemic. Acta Psychiatr Scand 56:241?248","journal-title":"Acta Psychiatr Scand"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00442567","volume":"99","author":"LH Lindstr\u00f6m","year":"1989","unstructured":"Lindstr\u00f6m LH (1989) A retrospective study on the long-term efficiency of clozapine in 96 schizophrenic and schizoaffective patients during a 13\u00a0year period. Psychopharmacology 99:584?586","journal-title":"Psychopharmacology"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00442573","volume":"99","author":"R Grohmans","year":"1989","unstructured":"Grohmans R, Schmidt LG, Spieb-Kiefer C, Ruther E (1989) Agranulocytosis and significant leucopenia with neuroleptic drugs. Results from the AMUP program. Psychopharmacology 99:109?112","journal-title":"Psychopharmacology"},{"key":"CR45","first-page":"44","volume":"55","author":"L Peacock","year":"1994","unstructured":"Peacock L, Gerlach J (1994) Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 55:44?49","journal-title":"J Clin Psychiatry"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2165\/00003495-199040050-00007","volume":"40","author":"A Fitton","year":"1990","unstructured":"Fitton A, Heel RC (1990) Clozapine: a review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs 40:722?747","journal-title":"Drugs"},{"issue":"4","key":"CR47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1440-1614.2001.0911f.x","volume":"35","author":"C Pantelis","year":"2001","unstructured":"Pantelis C, Adesanya A (2001) Increased risk of neutropenia and agranulocytosis with sodium valproate used adjunctively with clozapine. Aus N Z J Psychiatry 35(4):544?545","journal-title":"Aus N Z J Psychiatry"},{"key":"CR48","first-page":"567","volume":"28","author":"A S\u00e9n\u00e9chal","year":"2002","unstructured":"S\u00e9n\u00e9chal A, Landry P, Deschamps R, Lessard M (2002) Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs. Encephale 28:567?569","journal-title":"Encephale"},{"issue":"suppl 1","key":"CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-199200071-00009","volume":"7","author":"AV Pisciotta","year":"1992","unstructured":"Pisciotta AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA (1992) On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Saf 7 (suppl 1):33?44","journal-title":"Drug Saf"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1192\/bjp.164.6.850a","volume":"164","author":"D Beer","year":"1994","unstructured":"Beer D, Cope S, Paton C, Procter A, Wolfson P (1994) Clozapine-induced neutropenia, or not. Br J Psychiatry 164:850","journal-title":"Br J Psychiatry"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.152.1.153","volume":"152","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY, Okayli G (1995) Reduction of suicidality during clozapine treatment of neuroleptic resistant schizophrenia: impact on risk on risk-benefit assessment. Am J Psychiatry 152:183?190","journal-title":"Am J Psychiatry"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/070674379403900318","volume":"39","author":"R Dickson","year":"1984","unstructured":"Dickson R, Williams R, Dalby JT (1984) Dystonic reaction and relapse with clozapine discontinuation and risperidone initiation. Can J Psychiatry 39:184","journal-title":"Can J Psychiatry"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.1974.tb09706.x","volume":"50","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Koppelhus P, Helweg E, Manrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial. Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410?424","journal-title":"Acta Psychiatr Scand"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","volume":"21","author":"PJ Weiden","year":"1995","unstructured":"Weiden PJ, Olfson M (1995) Cost of relapse in schizophrenia. Schizophr Bull 21:419?429","journal-title":"Schizophr Bull"},{"issue":"S, suppl","key":"CR55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00442575","volume":"99","author":"P Krupp","year":"1989","unstructured":"Krupp P, Barnes P (1989) Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology 99(S, suppl):118?121","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0835-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0835-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0835-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:41:34Z","timestamp":1558701694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0835-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,30]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0835-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,30]]}}}